Advancis is developing a portfolio of antibiotics and anti-infective therapy products that includes two pulsatile antibiotics in Phase III clinical trials and four additional products in Phase I/II. These new pulsatile antibiotics are expected to redefine antibiotic infectious disease therapy...
Keywords: antibiotics infectious disease therapy anti infective products Advancis pharmaceutical antibiotic; antibiotics infectious disease therapy anti infective products Advancis pharmaceutical antibiotic
